biote Corp. (BTMD)

Market Cap	415.14M
Revenue (ttm)	185.36M
Net Income (ttm)	3.32M
Shares Out	74.53M
EPS (ttm)	0.13
PE Ratio	42.85
Forward PE	16.89
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,018
Open	5.48
Previous Close	5.55
Day's Range	5.48 - 5.80
52-Week Range	3.65 - 8.22
Beta	0.87
Analysts	Strong Buy
Price Target	8.11 (+45.6%)
Earnings Date	May 7, 2024

About BTMD

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; p...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2012
• Employees: 194
• Stock Exchange: NASDAQ
• Ticker Symbol: BTMD

Analyst Forecast

According to 5 analysts, the average rating for BTMD stock is "Strong Buy." The 12-month stock price forecast is $8.11, which is an increase of 45.60% from the latest price.

Price Target

$8.11

(45.60% upside)

Analyst Consensus: Strong Buy